Division of Tuberculosis Elimination
This year the Division of Tuberculosis Elimination (DTBE) would like to reflect on the research, resources, and events that shaped a momentous year. Here is a look back at some TB highlights for 2019.
On March 24, 2019, DTBE recognized World TB Day, an annual event to commemorate the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). The 2019 World TB Day theme was “It’s Time!” Activities in 2019 included the CDC U.S. TB Elimination Champions Project, a World TB Day Social Media Photo Challenge, the release of six short World TB Day Personal Stories videos, a World TB Day Twitter Storm, and a World TB Day event cohosted by DTBE and the Division of Global HIV and TB.
In April, public health laboratorians attended the APHL 11th National Conference on Laboratory Aspects of TB and the 2019 National TB Controllers Association (NTCA) National TB Conference held in Atlanta, Georgia. During the conference DTBE released an addition of a new educational module, Mycobacteriology False-Positive Case Studies to the Essentials for the Mycobacteriology Laboratory Promoting Quality Practices training module series. In this module, laboratorians can navigate through five real-world cases in which a false-positive MTBC result may have been reported.
DTBE published the 2018 surveillance report, Reported Tuberculosis in the United States, 2018. This was the first edition of the annual surveillance report published exclusively online. During 2018, the United States again reported the lowest number of TB cases (9,025) and lowest incidence rate (2.8 cases per 100,000 persons) on record. Although TB in the United States continues to decrease each year, the rate of decrease remains low. This low rate of decrease is most evident among the U.S.-born population, although most of reported TB cases continue to occur among non-U.S.–born persons.
In September, DTBE released the national TB program objectives and performance targets for 2025. The national objectives include decreasing TB incidence rates for both US-born (0.4 cases per 100,000) and non-US—born populations (8.8 cases per 100,000), as well as for US-born minorities (1.0 case per 100,000) and children less than five years of age (0.1 cases per 100,000). The objectives incorporate key process indicators for patient management, laboratory reporting, contact investigations of infectious TB patients, and follow-up examination of immigrants and refugees who recently arrived in the United States with Class B notifications.
Additionally, in September , the Republic of Palau and Global TB Institute co-hosted the Pacific Islands TB Controllers Association (PITCA) Conference and TB Surveillance Training. This event assembled TB experts from throughout the Pacific Islands and U.S. to engage in learning and discussion on the management and control of TB and provided training and networking opportunities for TB professionals in the region. On September 16–18, 2019, the Republic of Palau hosted a TB Surveillance Training following the 2019 PITCA Conference. There were 27 participants at the training, which included representatives from five of the USAPI jurisdictions.
In October, DTBE released the personal stories of four people diagnosed and treated for tuberculosis (TB) disease or latent TB infection. These stories are part of DTBE’s ongoing TB Personal Stories series to help raise awareness about TB in the United States. You can view the video, print, and social media content for each story by visiting CDC’s TB Personal Stories website. DTBE would like to thank We Are TB, The National TB Controllers Association, and the Stop TB USA for their contributions to this project.
.png)
No hay comentarios:
Publicar un comentario